Momoko Kitaoka
Overview
Explore the profile of Momoko Kitaoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kitaoka M, Nguyen T, Goto M
Int J Cosmet Sci
. 2021 Feb;
43(3):302-310.
PMID: 33566391
Objective: Nicotinamide, also known as niacinamide, is a water-soluble vitamin that is used to prevent and treat acne and pellagra. It is often found in water-based skin care cosmetics because...
2.
Kitaoka M, Oka A, Goto M
Pharmaceutics
. 2020 Sep;
12(9).
PMID: 32867263
An increasing number of protein vaccines have been researched for cancer, inflammation, and allergy therapies. Most of the protein therapeutics are administered through injection because orally-administered proteins are metabolized by...
3.
Kong Q, Kitaoka M, Wakabayashi R, Tahara Y, Kamiya N, Goto M
Pharmaceutics
. 2020 Mar;
12(3).
PMID: 32156090
Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan. Antigen-specific immunotherapy (AIT) is...
4.
Kitaoka M, Xiao W, Kong Q, Tahara Y, Kamiya N, Goto M
Pharmaceutics
. 2020 Mar;
12(3).
PMID: 32120968
An allergy to cow's milk proteins is the most common food allergy in infants and toddlers. Conventional oral immunotherapy for cow's milk allergies requires hospital admission due to the risk...
5.
Kong Q, Kitaoka M, Tahara Y, Wakabayashi R, Kamiya N, Goto M
Int J Pharm
. 2019 Nov;
572:118777.
PMID: 31678377
En masse vaccination is a promising strategy for combatting infectious diseases. Intranasal vaccination is a viable route of mass vaccination, and it could be performed easily via needle-free administration. However,...
6.
Kong Q, Higasijima K, Wakabayashi R, Tahara Y, Kitaoka M, Obayashi H, et al.
Pharmaceutics
. 2019 Nov;
11(11).
PMID: 31671640
Japanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet...
7.
Hardiningtyas S, Wakabayashi R, Kitaoka M, Tahara Y, Minamihata K, Goto M, et al.
Eur J Pharm Biopharm
. 2018 Feb;
127:44-50.
PMID: 29408222
Phycocyanin (PC), a water-soluble protein-chromophore complex composed of hexameric (αβ) subunits, has important biological functions in blue-green algae as well as pharmacological activities in biomedicine. We have previously developed a...
8.
Kitaoka M, Naritomi A, Kawabe Y, Kamihira M, Kamiya N, Goto M
Bioeng Transl Med
. 2018 Jan;
2(1):102-108.
PMID: 29313026
Antigen-specific immunotherapy is the only curative approach for the treatment of allergic diseases such as Japanese cedar pollinosis. Immunotherapy using a T cell epitope vaccine in combination with the adjuvant...
9.
Kong Q, Kitaoka M, Wakabayashi R, Kamiya N, Goto M
Int J Pharm
. 2017 Jul;
529(1-2):401-409.
PMID: 28705615
Pollinosis, a typical seasonal allergy, is a serious public health problem. Limited numbers of patients receive curative immunotherapy instead of symptomatic therapy; however, there are still some concerns about the...
10.
Kitaoka M, Wakabayashi R, Kamiya N, Goto M
Biotechnol J
. 2016 Aug;
11(11):1375-1385.
PMID: 27529824
Transdermal administration of drugs has advantages over conventional oral administration or administration using injection equipment. The route of administration reduces the opportunity for drug evacuation before systemic circulation, and enables...